Welcome to the Yokota Lab 

Dr. Toshifumi (Toshi) Yokota, PhD, FCAHS holds the prestigious Friends of Garrett Cumming Research & Muscular Dystrophy Canada Endowed Research Chair at the University of Alberta.

As a global leader in genetic therapeutics, Dr. Yokota directs a research program that is internationally recognized for its excellence and innovation in rare disease research. According to ScholarGPS (2024-25), the Yokota Lab ranks:

#1 in the world for research impact in Muscular Dystrophy (top 0.01%)
#3 in the world in Oligonucleotide Research (top 0.02%)
#3 in the world in Personalized Medicine (top 0.02%)

The lab is dedicated to improving the lives of individuals affected by devastating genetic conditions through the development of cutting-edge therapeutics—including RNA-targeted antisense oligonucleotides (ASOs), CRISPR-based genome editing, and personalized “n-of-1” medicines tailored to the unique genetic mutations of individual patients.